Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M H, Silbermann"'
Autor:
K. Groen, M. Seefat, K. Nasserinejad, C. A. Stege, E. van der Spek, Y. M. Bilgin, A. Kentos, M. Sohne, R. J. van Kampen, I. Ludwig, N. Thielen, N. Durdu-Rayman, N. C. de Graauw, N. W. van de Donk, E. G. de Waal, M.-C. Vekemans, G. J. Timmers, M. van der Klift, S. Soechit, P. A. Geerts, M. H. Silbermann, M. Oosterveld, I. Nijhof, P. Sonneveld, S. K. Klein, M.-D. Levin, S. Zweegman
Publikováno v:
HemaSphere, Vol 6, Pp 797-798 (2022)
Externí odkaz:
https://doaj.org/article/de7b33949bb645c785d0c3c2f76a5ff0
Autor:
M H, Silbermann, J M, Munneke
Publikováno v:
The Netherlands journal of medicine. 69(3)
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 151(32)
Erythrocytosis is a phenomenon with life-threatening complications and a broad differential diagnosis. Erythrocytosis is usually secondary to a cardiopulmonary condition leading to a low arterial oxygen tension. A probable diagnosis can often be made
Publikováno v:
Scandinavian journal of infectious diseases, 29(2), 199-201. Informa Healthcare
Scopus-Elsevier
Scopus-Elsevier
Melioidosis is a tropical infectious disease caused by Burkholderia (Pseudomonas) pseudomallei. Clinically manifest melioidosis occurs mostly in people with underlying disorders. Melioidosis is a disease with protean manifestations and a high rate of
Autor:
M H, Silbermann, P C, Stuiver
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 136(40)
From 1986 to 1990 we have treated 215 patients with falciparum malaria. In 8 patients (4%) who had not returned to any malarial area, malaria attacks recurred after 6-20 weeks. Curiously these were now caused by different species: Plasmodium vivax (4
Autor:
Kees Nooter, M. H. Silbermann, A. W. M. Boersma, A. L. W. Janssen, R. J. Scheper, Hans Herweijer
Publikováno v:
International journal of cancer. 44(4)
Multidrug-resistance (MDR) is characterized by the presence of a 170 kDa glycoprotein (P-glycoprotein) in the plasma membrane. P-glycoprotein is thought to act as an efflux pump, leading to reduced drug accumulation in MDR cells. This defect in drug